Simultaneous intermittent bleomycin and radiological treatment of laryngeal cancer.
Bleomycin has been shown to have a significant effect on squamous cell carcinomas, particularly on highly differentiated types. Applying combined bleomycin and x-rays simultaneously in an intermittent schedule, a synergistic effect was obtained. It was possible to lower the dosage of each and still achieve remarkable therapeutic responses. At the same time the side effects were reduced. The total dosages have been bleomycin 180 mg and x-rays 4.200 r skin dose, tumor dose approximately 2.500 r. Eighty-two laryngeal cases received such treatment. Altogether a complete regression was achieved in 62 per cent. Glottic tumors showed complete regression in 85 per cent. In six out of 10 inoperable cases, the tumor became surgically accessible by laryngectomy. In successfully treated patients characteristic histological changes were found, consisting in unusually large amounts of fully keratinized cells.
D000368:Aged; D000818:Animals; D001706:Biopsy; D001761:Bleomycin / Q000009:adverse effects / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000532:radiotherapy*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007633:Keratins / Q000378:metabolism; D007822:Laryngeal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D007830:Larynx / Q000473:pathology; D008297:Male; D051379:Mice; D008875:Middle Aged; D009664:Norway
D001761:Bleomycin; D007633:Keratins